ArticleBioinformation2026
Oral health considerations in patients receiving antidepressant therapy: Clinical implications and management strategies.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients receiving antidepressant therapy frequently present with oral health complications that are under recognized and inadequately addressed in routine dental practice. Antidepressant medications-particularly selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)-are widely prescribed and have significant implications for oral health. Their adverse effects include xerostomia, increased caries risk, periodontal disease and bruxism and delayed wound healing, while depression itself may contribute to poor oral hygiene practices and irregular dental attendance. Additionally, pharmacologic interactions with vasoconstrictors, analgesics, antibiotics and antifungals can complicate dental management, particularly in medically compromised and geriatric patients. This review integrates pharmacologic, behavioral and clinical considerations related to antidepressant use and translates existing evidence into practical strategies for comprehensive dental management, thereby providing a clinically relevant framework for dental practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.